Does/VBZ
thyroidectomy/NN
,/,
radioactive/JJ
iodine/NN
therapy/NN
,/,
or/CC
antithyroid/JJ
drug/NN
treatment/NN
alter/VB
reactivity/NN
of/IN
patients/NNS
'/POS
T/NN
cells/NNS
to/TO
epitopes/NNS
of/IN
thyrotropin/NN
receptor/NN
in/IN
autoimmune/JJ
thyroid/NN
diseases/NNS
?/.

The/DT
effect/NN
of/IN
treatment/NN
on/IN
thyroid/NN
antibody/NN
production/NN
and/CC
T/NN
cell/NN
reactivity/NN
to/TO
thyroid/NN
antigens/NNS
was/VBD
studied/VBN
in/IN
15/CD
patients/NNS
with/IN
Graves/NN
'/POS
disease/NN
(/(
GD/NN
)/)
before/IN
and/CC
after/IN
thyroidectomy/NN
,/,
19/CD
patients/NNS
with/IN
GD/NN
before/IN
and/CC
after/IN
radioactive/JJ
iodine/NN
(/(
RAI/NN
)/)
therapy/NN
,/,
and/CC
9/CD
patients/NNS
maintained/VBD
euthyroid/JJ
on/IN
antithyroid/JJ
drugs/NNS
(/(
ATD/NN
)/)
./.
=====
Twenty/CD
subjects/NNS
matched/JJ
for/IN
age/NN
and/CC
sex/NN
without/IN
known/JJ
thyroid/NN
disease/NN
served/VBD
as/IN
controls/NNS
./.
=====
In/IN
GD/NN
patients/NNS
,/,
the/DT
responses/NNS
of/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
(/(
PBMC/NN
)/)
and/CC
TSH/NN
receptor/NN
(/(
TSHR/NN
)/)
-specific/JJ
T/NN
cell/NN
lines/NNS
to/TO
recombinant/JJ
human/JJ
TSHR/NN
extracellular/JJ
domain/NN
,/,
thyroglobulin/NN
,/,
and/CC
TSHR/NN
peptides/NNS
were/VBD
examined/VBN
on/IN
the/DT
day/NN
of/IN
surgery/NN
or/CC
RAI/NN
therapy/NN
(/(
day/NN
0/CD
)/)
and/CC
also/RB
6-8/CD
weeks/NNS
and/CC
3-6/CD
months/NNS
thereafter/RB
./.
=====
Reactivity/NN
to/TO
TSHR/NN
peptides/NNS
before/IN
surgery/NN
was/VBD
heterogeneous/JJ
and/CC
spanned/VBD
the/DT
entire/JJ
extracellular/JJ
domain/NN
./.
=====
Six/CD
to/TO
8/CD
weeks/NNS
after/IN
subtotal/JJ
thyroidectomy/NN
,/,
the/DT
number/NN
of/IN
patients/NNS
'/POS
PBMC/NN
responding/VBG
to/TO
any/DT
peptide/NN
and/CC
the/DT
average/JJ
number/NN
of/IN
recognized/VBN
peptides/NNS
decreased/VBD
./.
=====
A/DT
further/JJ
decrease/NN
in/IN
the/DT
T/NN
cell/NN
reactivity/NN
to/TO
TSHR/NN
peptides/NNS
was/VBD
observed/VBN
3-6/CD
months/NNS
after/IN
surgery/NN
./.
=====
The/DT
responses/NNS
of/IN
PBMC/NN
from/IN
Graves/NN
'/POS
patients/NNS
before/IN
RAI/NN
therapy/NN
were/VBD
less/JJR
than/IN
those/DT
in/IN
the/DT
presurgical/JJ
group/NN
./.
=====
Six/CD
to/TO
8/CD
weeks/NNS
after/IN
RAI/NN
therapy/NN
,/,
the/DT
number/NN
of/IN
patients/NNS
responding/VBG
to/TO
any/DT
peptide/NN
and/CC
the/DT
average/JJ
number/NN
of/IN
recognized/VBN
peptides/NNS
increased/VBD
./.
=====
Three/CD
to/TO
6/CD
months/NNS
after/IN
RAI/NN
,/,
T/NN
cell/NN
responses/NNS
to/TO
TSHR/NN
peptides/NNS
were/VBD
less/JJR
than/IN
those/DT
6-8/CD
weeks/NNS
after/IN
RAI/NN
therapy/NN
,/,
but/CC
still/RB
higher/JJR
than/IN
the/DT
values/NNS
on/IN
day/NN
0/CD
./.
=====
Responses/NNS
of/IN
PBMC/NN
from/IN
patients/NNS
with/IN
GD/NN
,/,
maintained/VBD
euthyroid/JJ
on/IN
ATD/NN
,/,
were/VBD
lower/JJR
than/IN
those/DT
before/IN
surgery/NN
or/CC
RAI/NN
therapy/NN
./.
=====
The/DT
reactivity/NN
of/IN
T/NN
cell/NN
lines/NNS
in/IN
different/JJ
groups/NNS
reflected/VBD
a/DT
pattern/NN
similar/JJ
to/TO
PBMC/NN
after/IN
treatment/NN
./.
=====
TSHR/NN
antibody/NN
and/CC
microsomal/JJ
antibody/NN
levels/NNS
decreased/VBD
after/IN
surgery/NN
,/,
but/CC
increased/VBD
after/IN
RAI/NN
therapy/NN
./.
=====
The/DT
difference/NN
in/IN
the/DT
number/NN
of/IN
recognized/VBN
peptides/NNS
by/IN
patients/NNS
'/POS
PBMC/NN
before/IN
RAI/NN
and/CC
surgery/NN
may/MD
reflect/VB
the/DT
effect/NN
of/IN
long/JJ
term/NN
therapy/NN
with/IN
ATD/NN
in/IN
the/DT
patients/NNS
before/IN
RAI/NN
vs./CC
the/DT
shorter/JJR
period/NN
in/IN
patients/NNS
before/IN
surgery/NN
./.
=====
The/DT
decreased/VBN
T/NN
cell/NN
reactivity/NN
to/TO
thyroid/NN
antigens/NNS
after/IN
thyroidectomy/NN
could/MD
be/VB
the/DT
result/NN
of/IN
removal/NN
of/IN
a/DT
major/JJ
part/NN
of/IN
the/DT
thyroid/NN
gland/NN
or/CC
redistribution/NN
of/IN
suppressor-inducer/JJ
T/NN
cells/NNS
./.
=====
The/DT
increased/VBN
T/NN
cell/NN
response/NN
after/IN
RAI/NN
therapy/NN
is/VBZ
probably/RB
epitope/NN
specific/JJ
,/,
rather/RB
than/IN
a/DT
response/NN
to/TO
the/DT
whole/JJ
TSHR/NN
molecule/NN
./.
=====
Synchronous/JJ
recognition/NN
of/IN
peptides/NNS
158-176/CD
and/CC
248-263/CD
is/VBZ
important/JJ
for/IN
the/DT
development/NN
of/IN
GD/NN
,/,
and/CC
the/DT
loss/NN
of/IN
recognition/NN
of/IN
one/CD
of/IN
these/DT
epitopes/NNS
may/MD
be/VB
an/DT
early/JJ
sign/NN
of/IN
immune/JJ
remission/NN
and/CC
a/DT
predictor/NN
of/IN
euthyroidism/NN
./.